Reports Q4 revenue $210.3M, consensus $202.9M. “We ended 2024 on a high note with fourth quarter and full-year total revenue and adjusted ...

Stephens analyst Charles Nabhan maintained a Buy rating on Q2 Holdings (QTWO – Research Report) today and set a price target of $115.00. The ...

The Gastro+™ is easy-to-use and a non-invasive breath hydrogen monitor, with two sampling modes and a colour touch screen. The monitor is quick and easy use, with visual prompts for patients ...